European Archives - Page 275 of 1154 - European Medical Journal

COVID-19 Vaccine Does Not Increase Multiple Sclerosis Relapse Risk

A new study involving 124,545 MS patients reveals that COVID-19 vaccination does not significantly increase relapse risk, except in those with highly active, untreated MS.

Chemotherapy-Induced Gut Microbiome Changes Linked to Cognitive Decline

A new study found a significant link between chemotherapy-induced disruptions in the gut microbiome and cognitive decline in female patients with breast cancer.

European Commission gives green light to Roche’s PNH treatment

Roche has secured European Commission approval for its drug crovalimab, marking a significant advancement in the treatment of PNH.

Understanding Developmental and Epileptic Encephalopathies

Developmental and epileptic encephalopathy (DEE) refers to a collection of rare and severe epilepsies that feature both seizures and…

EMJ Neurology 12 [Supplement 3] 2024

This article summarises a fascinating interview with neurologist Antonietta Coppola, University of Naples Federico II, Italy, in which she…

joint pain from gout

Light Alcohol Cuts Gout Risk in Women, But Increases in Men

A RECENT study has found a link between alcohol consumption and the risk of developing gout.

Liver Stiffness Identified as an Indicator of Hepatitis C Risk

Recent studies suggest liver stiffness as the primary indicator for assessing long-term risk after Hepatitis C virus treatment

Novel Non-invasive Model to Detect Varices in Hepatocellular Carcinoma

A new model combining clinical and imaging data effectively predicts the absence of high-risk varices in patients with unresectable hepatocellular carcinoma

Lecanemab Binds Amyloid Plaques in People with Down Syndrome

A new study reveals that an Alzheimer’s drug, binds effectively to amyloid plaques in people with Down syndrome but raises safety concerns due to its interaction with brain blood vessels.

Genetic Switches Drive Mutation in Colorectal Cancer

A new study has uncovered a mechanism that drives the evolution of mismatch repair deficient colorectal cancer, a type of cancer known for its high mutation rates.